Latest Governance News

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Haranga Resources is poised to complete its acquisition of the Lincoln Gold Project in California, bolstered by strong due diligence results, while advancing uranium and gold exploration projects in Senegal with permit renewals and maiden drilling.

Lion Energy has made steady progress on its Port of Brisbane Green Hydrogen Project while moving closer to securing funding for a key drilling operation in Indonesia’s East Seram PSC.

Lion Energy Limited reported a net cash outflow in Q2 2025 but maintains a solid cash position of AUD 2.13 million alongside a convertible note facility, signaling cautious optimism for its exploration activities.

Battery Age Minerals Ltd has responded to an ASX price query, denying undisclosed information and attributing recent trading activity to a new research report and the launch of its maiden drilling program.

Tennant Minerals has identified a significant copper anomaly at its Bluebird East prospect, mirroring the high-grade Bluebird discovery, while advancing large-scale gold-copper targets at its Barkly Project in the Northern Territory.

Hot Chili Limited confirms a significant copper-gold mineralisation footprint at its La Verde discovery in Chile, completing phase-one drilling and advancing strategic funding discussions for its key projects.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

Mount Burgess Mining advances metallurgical test work at its Nxuu deposit, navigates leadership changes, and pursues a significant legacy debt extinguishment as it refines its strategic focus.

GTN Limited shareholders have overwhelmingly approved a capital return, setting the stage for a payment scheduled on 11 August 2025. This move reflects the company’s ongoing strategy to optimise shareholder value.

Holista Colltech reported steady customer receipts and a 38% surge in dietary supplement sales for 2QFY25, while progressing its high-value nano-collagen business and refreshing its leadership team.

Gullewa Limited reported a solid cash balance of A$8.1 million at the end of June 2025, supported by positive operating cash flow despite ongoing investment in exploration and corporate activities.